Table 3 Reasons to participate and not to participate in the four hypothetical protocols
H1: Oral medication | ||
Reasons to participate | Mexico (n=45) | U.S. (n=14) |
Benefits outweigh the risk | 30 (67%) | 10 (71%) |
Help future generations | 39 (87%) | 13 (93%) |
Other | 0 (0%) | 1 (7%) |
Reasons to decline participation | (n= 4) | (n=9) |
Do not want to know my genetic status | 1 (25%) | 5 (56%) |
Risks and side effects are too high to justify possible benefits | 1 (25%) | 2 (22%) |
Other | 2 (50%) | 3 (33%) |
H2: Vaccine trial | ||
Reasons to participate | (n=34) | (n=12) |
Benefits outweight the risk | 21 (62%) | 8 (67%) |
Help future generations | 25 (74%) | 8 (67%) |
Other | 1 (3%) | 1 (8%) |
Reasons to decline participation | (n=14) | (n=10) |
Do not want to know my genetic status | 0 (0%) | 5 (50%) |
Risks and side effects are too high to justify possible benefits | 12 (86%) | 4 (40%) |
Other | 1 (7%) | 0 (0%) |
H3: Intravenous drug trial | ||
Reasons to participate | (n=33) | (n=9) |
Benefits outweight the risk | 22 (67%) | 7 (78%) |
Help future generations | 28 (85%) | 7 (78%) |
Other | 1 (3%) | 0 (0%) |
Reasons to decline participation | (n=16) | (n=12) |
Do not want to know my genetic status | 4 (25%) | 7 (58%) |
Risks and side effects are too high to justify possible benefits | 9 (56%) | 4 (33%) |
Other | 3 (19%) | 1 (8%) |
H4: Neurosurgery | ||
Reasons to participate | (n=16) | (n=3) |
Benefits outweight the risk | 10 (62%) | 2 (67%) |
Help future generations | 15 (94%) | 2 (67%) |
Other | 0 (0%) | 0 (0%) |
Reasons to decline participation | (n=30) | (n=18) |
Do not want to know my genetic status | 3 (10%) | 7 (39%) |
Risks and side effects are too high to justify possible benefits | 23 (77%) | 11 (61%) |
Other | 5 (17%) | 3 (17%) |